Predictive Role of sTREM in Endovascular Thrombectomy Outcomes
Soluble Soluble Triggering Receptors Expressed on Myeloid Cells (sTREM) Predict Outcomes in Stroke Patients Receiving Endovascular Thrombectomy
The Affiliated Hospital of Xuzhou Medical University
300 participants
Jul 1, 2024
OBSERVATIONAL
Conditions
Summary
Soluble triggering receptor expressed on myeloid cells (sTREM), which reflects microglia activation, has been reported closely associated with neuronal injury and neuroinflammation. This study is to investigatethe prognostic roles of sTREM (sTREM1 and sTREM2) in patients with ischemic stroke who underwent endovascular thrombectomy (EVT).
Eligibility
Inclusion Criteria2
- Patients > 18 years old.
- Patients with acute large vessel occlusion within 24 hours of onset who will receive endovascular treatment.
Exclusion Criteria3
- Impossibility of getting a blood sample.
- Impossibility of performing the test (Invalid results).
- Refusal to provide the informed consent by the patient/relative.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06545591